1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1532/HSF98.20121103" target="_blank" rel="noreferrer noopener">http://doi.org/10.1532/HSF98.20121103</a>
Pages
E60–69
Issue
2
Volume
16
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
Publisher
An entity responsible for making the resource available
The heart surgery forum
Date
A point or period of time associated with an event in the lifecycle of the resource
2013
2013-04
Subject
The topic of the resource
Adult; Female; Humans; Male; Middle Aged; Aged; Treatment Outcome; Prevalence; United States/epidemiology; Risk Assessment; Adenosine Monophosphate/administration & dosage/*analogs & derivatives; Blood Transfusion/*statistics & numerical data; Coronary Artery Bypass/*statistics & numerical data; Drug-Related Side Effects and Adverse Reactions/epidemiology; Placebo Effect; Platelet Aggregation Inhibitors/administration & dosage; Postoperative Hemorrhage/*epidemiology/*prevention & control; Premedication/*statistics & numerical data; Purinergic P2Y Receptor Antagonists/administration & dosage; Pyridines/*administration & dosage; Injections; 80 and over; Intravenous; Administration; Drug Therapy; Oral; Combination/statistics & numerical data
Creator
An entity primarily responsible for making the resource
Firstenberg Michael S; Dyke Cornelius M; Angiolillo Dominick J; Ramaiahm Chandrashekar; Price Matthew; Brtko Miroslav; Welsby Ian; Chandna Harish; Holmes David R; Voeltz Michele; Tummala Pradyumna; Hutyra Martin; Manoukian Steven V; Prats Jayne; Todd Meredith; Liu Tiepu; Chronos Nicholas; Dietrich Markus; Montalescot Gilles; Cannon Louis A; Topo Eric J
Description
An account of the resource
OBJECTIVE: Oral P2Y(1)(2) platelet receptor inhibitors are a cornerstone of reducing complications in patients with acute coronary syndromes or coronary stents. Guidelines advocate discontinuing treatment with P2Y(1)(2) platelet receptor inhibitors before surgery. Cangrelor, a short-acting, reversible, intravenously administered P2Y(1)(2) platelet inhibitor is effective in achieving appropriate platelet inhibition in patients who are awaiting coronary artery bypass grafting (CABG) and require P2Y(1)(2) inhibition. The objective of this study was to assess the effects of preoperative cangrelor on the incidence of perioperative complications, which are currently unknown. METHODS: Patients (n = 210) requiring preoperative clinical administration of thienopyridine therapy were randomized in a multicenter, double-blinded study to receive cangrelor or placebo while awaiting CABG after discontinuation of the thienopyridine. Optimal platelet reactivity, which was defined as \textless240 P2Y(1)(2) platelet reaction units, was measured with serial point-of-care testing (VerifyNow). Pre- and postoperative outcomes, bleeding values, and transfusion rates were compared. To quantify potential risk factors for bleeding, we developed a multivariate logistic model. RESULTS: The differences between the groups in bleeding and perioperative transfusion rates were not significantly different. The rate of
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1532/HSF98.20121103" target="_blank" rel="noreferrer noopener">10.1532/HSF98.20121103</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2013
80 and over
Adenosine Monophosphate/administration & dosage/*analogs & derivatives
Administration
Adult
Aged
Angiolillo Dominick J
Blood Transfusion/*statistics & numerical data
Brtko Miroslav
Cannon Louis A
Chandna Harish
Chronos Nicholas
Combination/statistics & numerical data
Coronary Artery Bypass/*statistics & numerical data
Dietrich Markus
Drug Therapy
Drug-Related Side Effects and Adverse Reactions/epidemiology
Dyke Cornelius M
Female
Firstenberg Michael S
Holmes David R
Humans
Hutyra Martin
Injections
Intravenous
Liu Tiepu
Male
Manoukian Steven V
Middle Aged
Montalescot Gilles
Oral
Placebo Effect
Platelet Aggregation Inhibitors/administration & dosage
Postoperative Hemorrhage/*epidemiology/*prevention & control
Prats Jayne
Premedication/*statistics & numerical data
Prevalence
Price Matthew
Purinergic P2Y Receptor Antagonists/administration & dosage
Pyridines/*administration & dosage
Ramaiahm Chandrashekar
Risk Assessment
The heart surgery forum
Todd Meredith
Topo Eric J
Treatment Outcome
Tummala Pradyumna
United States/epidemiology
Voeltz Michele
Welsby Ian